BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenström’s Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting
/
Date06 Dec 2016
WALTHAM, Mass., Dec. 05, 2016 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ:BGNE) a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of... Read More →
Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies
/
Date06 Dec 2016
– Overall Response Rate of 38% and Complete Remission Rate of 18% with Patients on Study up to 24.2 Months – – For Relapsed/Refractory Acute... Read More →
The Eye Doctors Host an Event on December 7 to Celebrate the Launch of Their Men’s Premier Red Bull Eyewear Line
/
Date06 Dec 2016
TAMPA, Fla., Dec. 05, 2016 (GLOBE NEWSWIRE) — The Eye Doctors of Florida are pleased to announce that they will be hosting an end of... Read More →
TiGenix kondigt start aan van beoogd initieel openbaar aanbod in de Verenigde Staten
/
Date05 Dec 2016
Leuven, Belgium, Dec. 05, 2016 (GLOBE NEWSWIRE) — PERSBERICHT GEREGLEMENTEERDE INFORMATIE TiGenix kondigt start aan van beoogd initieel openbaar aanbod in de Verenigde Staten Leuven... Read More →
TiGenix annonce le lancement de son introduction en bourse envisagée aux Etats-Unis
/
Date05 Dec 2016
Leuven, Belgium, Dec. 05, 2016 (GLOBE NEWSWIRE) — COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE TiGenix annonce le lancement de son introduction en bourse envisagée aux Etats-Unis... Read More →
TiGenix announces launch of proposed initial public offering in the United States
/
Date05 Dec 2016
Leuven, Belgium, Dec. 05, 2016 (GLOBE NEWSWIRE) — PRESS RELEASE REGULATED INFORMATION TiGenix announces launch of proposed initial public offering in the United States Leuven... Read More →
Talyst and McFarlane Medical Announce Partnership
/
Date05 Dec 2016
KIRKLAND, Wash., Dec. 5, 2016 (GLOBE NEWSWIRE) — Talyst, a market leader in pharmacy automation and medication management solutions, and McFarlane Medical, a developer, manufacturer... Read More →
Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study
/
Date05 Dec 2016
– PRO designed to establish clinical benefit – — First time a PRO to be used as a secondary clinical endpoint in a SCD registrational... Read More →
BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia at the 2016 American Society of Hematology Annual Meeting
/
Date05 Dec 2016
WALTHAM, Mass, Dec. 05, 2016 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ:BGNE) a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of... Read More →
American Health Council Names Janet Allan, PhD, APRN, FAAN to Education Board
/
Date05 Dec 2016
Dr. Janet Allan, Dean Emeritus at the University of Maryland, Baltimore, has been selected to join the Education Board at the American Health Council. NEW... Read More →